Literature DB >> 9129358

Alexithymia in a clinical sample of obese women.

A Morosin1, G Riva.   

Abstract

The purpose was to examine the rate of alexithymia as measured by the Toronto Alexithymia Scale in a clinical sample of obese women without Binge Eating Disorder. Subjects included 165 inpatients in an eating disorder unit and 135 normal-weight individuals (comparison group). The obese subjects also completed a series of tests including the Minnesota Multiphasic Personality Inventory, the Anxiety Scale Questionnaire, and the Eating Attitude Test. Analysis showed that the subgroups of obese persons differ in important ways and cannot necessarily be treated, studied, or understood through a single paradigm. Alexithymic behaviour, too, was not characteristic of obesity, but it was present only in the subgroup of subjects with psychopathological characteristics.

Entities:  

Mesh:

Year:  1997        PMID: 9129358     DOI: 10.2466/pr0.1997.80.2.387

Source DB:  PubMed          Journal:  Psychol Rep        ISSN: 0033-2941


  4 in total

1.  Evaluation of alexithymia and depression in severe obese patients not affected by eating disorders.

Authors:  A Da Ros; P Vinai; N Gentile; G Forza; S Cardetti
Journal:  Eat Weight Disord       Date:  2011-03       Impact factor: 4.652

2.  Obesity, psychopathology and eating attitudes: are they related?

Authors:  G Riva; P Ragazzoni; E Molinari
Journal:  Eat Weight Disord       Date:  1998-06       Impact factor: 4.652

3.  Obesity, alexithymia and psychopathology: a case-control study.

Authors:  F Pinna; L Lai; S Pirarba; W Orrù; F Velluzzi; A Loviselli; B Carpiniello
Journal:  Eat Weight Disord       Date:  2011-02-16       Impact factor: 4.652

4.  Personality and psychopathology differences between bariatric surgery candidates, subjects with obesity not seeking surgery management, and healthy subjects.

Authors:  Amianto Federico; Angela Valentina Spalatro; Ilari Giorgio; Marzola Enrica; Giovanni Abbate Daga; Fassino Secondo
Journal:  Eat Weight Disord       Date:  2019-05-06       Impact factor: 4.652

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.